Back to Journals » Therapeutics and Clinical Risk Management » Volume 8

Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data

Total article views   HTML views PDF downloads Totals
11,616 Dovepress* 9,295+ 1,492 10,787
PubMed Central* 2,321 337 2,658
Totals 11,616 1,829 13,445
*Since 20 June 2012
+Since July 2016

View citations on PubMed Central and Google Scholar